← All trials
NCT02341560
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2015
- Primary completion
- Jul 1, 2019
- Completion date
- Jul 1, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 530
- Arms / groups
- 5 / —
- Source
- AACT · pre-existing
Sponsors
- Quark PharmaceuticalsLead sponsor
- Quark PharmaceuticalsStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.